Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
- 10 July 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 24 (9), 1759-1771
- https://doi.org/10.1007/s11095-007-9379-0
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across the Blood−Brain Barrier and Aβ Fibril DisaggregationBioconjugate Chemistry, 2007
- Mining a yeast library for brain endothelial cell-binding antibodiesNature Methods, 2007
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Delivery of β-Galactosidase to Mouse Brain via the Blood-Brain Barrier Transferrin ReceptorThe Journal of pharmacology and experimental therapeutics, 2005
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Neuroprotection in Transient Focal Brain Ischemia After Delayed Intravenous Administration of Brain-Derived Neurotrophic Factor Conjugated to a Blood-Brain Barrier Drug Targeting SystemStroke, 2001
- Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injectionsBrain Research, 1996
- Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated miceExperimental Neurology, 1991
- Molecular and Cellular Mechanisms of Receptor-Mediated EndocytosisDNA and Cell Biology, 1991
- Developmental changes in transferrin and iron uptake by the brain in the ratDevelopmental Brain Research, 1990